Poly(ADP-ribose) Polymerase Inhibitor Combinations in First-Line Metastatic Castration-Resistant Prostate Cancer: Increasing Toxicity with Unclear Benefits

Ravi A. Madan; Fatima Karzai; David J. Vanderweele; Heather H. Cheng; Johann S. De Bono

doi:10.1200/JCO.23.01502

Poly(ADP-ribose) Polymerase Inhibitor Combinations in First-Line Metastatic Castration-Resistant Prostate Cancer: Increasing Toxicity with Unclear Benefits

Ravi A. Madan^*, Fatima Karzai, David J. Vanderweele, Heather H. Cheng, Johann S. De Bono

^*Corresponding author for this work

Medicine, Hematology Oncology Division

Research output: Contribution to journal › Comment/debate › peer-review

3 Scopus citations

Original language	English (US)
Pages (from-to)	5501-5504
Number of pages	4
Journal	Journal of Clinical Oncology
Volume	41
Issue number	36
DOIs	https://doi.org/10.1200/JCO.23.01502
State	Published - Dec 20 2023

ASJC Scopus subject areas

Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1200/JCO.23.01502

Cite this

@article{b76fc6f217a8484c99392f8898fb13e5,

title = "Poly(ADP-ribose) Polymerase Inhibitor Combinations in First-Line Metastatic Castration-Resistant Prostate Cancer: Increasing Toxicity with Unclear Benefits",

author = "Madan, {Ravi A.} and Fatima Karzai and Vanderweele, {David J.} and Cheng, {Heather H.} and {De Bono}, {Johann S.}",

year = "2023",

month = dec,

day = "20",

doi = "10.1200/JCO.23.01502",

language = "English (US)",

volume = "41",

pages = "5501--5504",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams and Wilkins",

number = "36",

}

Poly(ADP-ribose) Polymerase Inhibitor Combinations in First-Line Metastatic Castration-Resistant Prostate Cancer: Increasing Toxicity with Unclear Benefits. / Madan, Ravi A.; Karzai, Fatima; Vanderweele, David J. et al.
In: Journal of Clinical Oncology, Vol. 41, No. 36, 20.12.2023, p. 5501-5504.

Research output: Contribution to journal › Comment/debate › peer-review

TY - JOUR

T1 - Poly(ADP-ribose) Polymerase Inhibitor Combinations in First-Line Metastatic Castration-Resistant Prostate Cancer

T2 - Increasing Toxicity with Unclear Benefits

AU - Madan, Ravi A.

AU - Karzai, Fatima

AU - Vanderweele, David J.

AU - Cheng, Heather H.

AU - De Bono, Johann S.

PY - 2023/12/20

Y1 - 2023/12/20

UR - http://www.scopus.com/inward/record.url?scp=85180009579&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85180009579&partnerID=8YFLogxK

U2 - 10.1200/JCO.23.01502

DO - 10.1200/JCO.23.01502

M3 - Comment/debate

C2 - 37847874

AN - SCOPUS:85180009579

SN - 0732-183X

VL - 41

SP - 5501

EP - 5504

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 36

ER -

Poly(ADP-ribose) Polymerase Inhibitor Combinations in First-Line Metastatic Castration-Resistant Prostate Cancer: Increasing Toxicity with Unclear Benefits

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this